Search: 
You do not have permission to access this chart.
Please Sign Up or Login
News for Vincerx Pharma, Inc. (VINC)
Newly released Crypto mining rig for Vincerx Pharma, Inc. coins
minutes ago | Banggood.com
Everything Crypto on sale now!
58 minutes ago | Aliexpress.com
Vincerx Pharma Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
2 days ago | GlobeNewsWire
UPDATE -- Vincerx Pharma Presents Clinical Data on VIP152, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021
2 months ago | GlobeNewsWire
Vincerx Pharma Presents Clinical Data on VIP512, its PTEFb/CDK9 Inhibitor, in Patients with Double-Hit Lymphoma at ASCO 2021
2 months ago | GlobeNewsWire
Vincerx Pharma Announces First Patient Dosed in Phase 1b Study of VIP152 in MYC-Driven Relapsed or Refractory Aggressive Lymphomas and Advanced Solid Tumors
2 months ago | GlobeNewsWire
Vincerx Pharma to Participate in the Jefferies Virtual Healthcare Conference
2 months ago | GlobeNewsWire
Vincerx Pharma Reports First Quarter 2021 Financial Results and Provides a Corporate Update
3 months ago | GlobeNewsWire
Vincerx Pharma Announces FDA Clearance of IND for Phase 1b Study of VIP152 in Chronic Lymphocytic Leukemia and Richter Syndrome
3 months ago | GlobeNewsWire
Vincerx Pharma Presents Preclinical Data on VIP236, its Lead Small Molecule Drug Conjugate, at the American Association for Cancer Research Annual Meeting 2021
4 months ago | GlobeNewsWire
Vincerx Pharma To Host Key Opinion Leader Webinar on Bioconjugation and CDK9 Inhibitors for the Treatment of Hematologic and Solid Tumors
4 months ago | GlobeNewsWire
Vincerx Pharma Announces Redemption of Public Warrants
4 months ago | GlobeNewsWire

About:

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company’s lead product candidate is VIP152 that is in clinical trials. Its drug candidates are in development for the treatment of solid tumors, leukemia, B-cell malignancies, lymphomas, and myelodysplastic syndrome. Vincerx Pharma, Inc. is based in Palo Alto, California.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

28

Address:

Vincerx Pharma, Inc. 260 Sheridan Avenue Suite 400 Palo Alto CA 94306 United States

Website:

Home

Phone:

650-800-6676

Leave a comment

Your email address will not be published. Required fields are marked *